Antioxidant and tyrosinase inhibitory effects of neolignan glycosides from Crataegus pinnatifida seeds
Georg Thieme Verlag KG Stuttgart · New York..
In our efforts to find an inhibitor of melanin formation and develop potential depigmenting agents for skin-protecting cosmetics and medicinal products from natural resources, we focused on the seeds of Crataegus pinnatifida which showed antioxidant and tyrosinase-inhibiting activities. By activity-guided fractionation of an extract of C. pinnatifida seeds, four new neolignan glycosides, pinnatifidaninsides A-D (1-4), along with two known compounds (5-6), were isolated. Their structures were elucidated by spectroscopic analyses, especially 1D, 2D NMR and CD spectra. The antioxidant and tyrosinase-inhibiting activities of all isolates were assayed. Compound 6 showed good activity against 2,2-diphenyl-1-pikrylhydrazyl, while compounds 1, 2, 5, and 6 exhibited strong 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) free radical scavenging activity, being as effective as, or even more effective than the positive control Trolox. Moreover, compounds 5 and 6 displayed a moderate mushroom tyrosinase inhibitory activity.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:80 |
---|---|
Enthalten in: |
Planta medica - 80(2014), 18 vom: 11. Dez., Seite 1732-8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Huang, Xiao-Xiao [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antioxidants |
---|
Anmerkungen: |
Date Completed 25.08.2015 Date Revised 17.12.2014 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1055/s-0034-1383253 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM243355475 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM243355475 | ||
003 | DE-627 | ||
005 | 20231224132343.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1055/s-0034-1383253 |2 doi | |
028 | 5 | 2 | |a pubmed24n0811.xml |
035 | |a (DE-627)NLM243355475 | ||
035 | |a (NLM)25377118 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Huang, Xiao-Xiao |e verfasserin |4 aut | |
245 | 1 | 0 | |a Antioxidant and tyrosinase inhibitory effects of neolignan glycosides from Crataegus pinnatifida seeds |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.08.2015 | ||
500 | |a Date Revised 17.12.2014 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Georg Thieme Verlag KG Stuttgart · New York. | ||
520 | |a In our efforts to find an inhibitor of melanin formation and develop potential depigmenting agents for skin-protecting cosmetics and medicinal products from natural resources, we focused on the seeds of Crataegus pinnatifida which showed antioxidant and tyrosinase-inhibiting activities. By activity-guided fractionation of an extract of C. pinnatifida seeds, four new neolignan glycosides, pinnatifidaninsides A-D (1-4), along with two known compounds (5-6), were isolated. Their structures were elucidated by spectroscopic analyses, especially 1D, 2D NMR and CD spectra. The antioxidant and tyrosinase-inhibiting activities of all isolates were assayed. Compound 6 showed good activity against 2,2-diphenyl-1-pikrylhydrazyl, while compounds 1, 2, 5, and 6 exhibited strong 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) free radical scavenging activity, being as effective as, or even more effective than the positive control Trolox. Moreover, compounds 5 and 6 displayed a moderate mushroom tyrosinase inhibitory activity | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Enzyme Inhibitors |2 NLM | |
650 | 7 | |a Glycosides |2 NLM | |
650 | 7 | |a Lignans |2 NLM | |
650 | 7 | |a Monophenol Monooxygenase |2 NLM | |
650 | 7 | |a EC 1.14.18.1 |2 NLM | |
700 | 1 | |a Liu, Qing-Bo |e verfasserin |4 aut | |
700 | 1 | |a Wu, Jie |e verfasserin |4 aut | |
700 | 1 | |a Yu, Li-Hong |e verfasserin |4 aut | |
700 | 1 | |a Cong, Qian |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yan |e verfasserin |4 aut | |
700 | 1 | |a Lou, Li-Li |e verfasserin |4 aut | |
700 | 1 | |a Li, Ling-Zhi |e verfasserin |4 aut | |
700 | 1 | |a Song, Shao-Jiang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Planta medica |d 1961 |g 80(2014), 18 vom: 11. Dez., Seite 1732-8 |w (DE-627)NLM000844535 |x 1439-0221 |7 nnns |
773 | 1 | 8 | |g volume:80 |g year:2014 |g number:18 |g day:11 |g month:12 |g pages:1732-8 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/s-0034-1383253 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 80 |j 2014 |e 18 |b 11 |c 12 |h 1732-8 |